Do incentives from Big Pharma influence the way doctors treat cancer patients? A study published earlier this year in JAMA Oncology says YES.
The first study to evaluate reimbursement policies and clinical care in oncology, the review found that oncologists often change their treatment recommendations and prescriptions based on incentives from the pharmaceutical industry.
(Natural News) President Trump is draining the “medical swamp.” The U.S. health care system is plagued by rampant fraud, abuse and profiteering carried out by dishonest doctors and pharmacists. In working to combat the rampant fraud, the DOJ has announced an unprecedented crackdown on medical fraud, charging over 600 people with criminal activities that involved…Read more